Chronic Lymphocytic Leukemia - Treatment Options, Symptoms, Causes & Diagnosis from MedifocusHealth

Chronic Lymphocytic Leukemia > What Your Doctor is Reading About Chronic Lymphocytic Leukemia > General Interest Articles

General Interest Articles

1. Staging chronic lymphocytic leukemia (CLL) for prognosis at diagnosis.

Author: Zent CS; Polliack A;
Institution: Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. zent.clive@mayo.edu
Journal: Leuk Lymphoma. 2006 Dec;47(12):2433-4.

2. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia.

Author: Mayr C; Speicher MR; Kofler DM; Buhmann R; Strehl J; Busch R; Hallek M; Wendtner CM;
Institution: Gesellschaft fur Strahlenforschung (GSF)-National Research Center for Environment and Health, Munich, Germany.
Journal: Blood. 2006 Jan 15;107(2):742-51. Epub 2005 Sep 22.
Abstract URL: Click here to view abstract

3. Chronic lymphocytic leukemia: current and emerging treatment approaches.

Author: Kay NE; Rai KR; O'brien S;
Institution: Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Journal: Clin Adv Hematol Oncol. 2006 Nov;4(11 Suppl 22):1-12.
Abstract URL: Click here to view abstract

4. Graft-versus-leukemia in chronic lymphocytic leukemia.

Author: Ben-Bassat I; Raanani P; Gale RP;
Institution: Institute of Hematology, The Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Journal: Bone Marrow Transplant. 2007 Apr;39(8):441-6. Epub 2007 Feb 26.
Abstract URL: Click here to view abstract

5. Prognostic nomogram and index for overall survival in previously untreated patients with chronic lynmphocytic leukmeia.

Author: Wierda WG; O'brien S; Wang X; Faderl S; Ferrajoli A; Do KA; Cortes J; Thomas D; Garcia-Manero G; Koller C; Beran M; Giles F; Ravandi F; Lerner S; Kantarjian H; Keating M;
Institution: Department of Leukemia, U.T. MD Anderson Cancer Center, Houston, TX.
Journal: Blood. 2007 Feb 13;.
Abstract URL: Click here to view abstract

6. Personal use of hair dyes and hematolymphopoietic malignancies.

Author: Miligi L; Costantini AS; Benvenuti A; Veraldi A; Tumino R; Ramazzotti V; Vindigni C; Amadori D; Fontana A; Rodella S; Stagnaro E; Crosignani P; Vineis P;
Institution: Instituto Toscano Tumori-Unit of Environmental and Occupational Epidemiology, Centre for Study and Cancer Prevention, Florence, Italy. l.miligi@cspo.it
Journal: Arch Environ Occup Health. 2005 Sep-Oct;60(5):249-56.
Abstract URL: Click here to view abstract

7. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.

Author: Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS;
Institution: Department of Genetics, University of Nebraska Medical Center, Omaha, NE 68198-6395, USA.
Journal: Int J Mol Med. 2007 Oct;20(4):461-9.
Abstract URL: Click here to view abstract

8. Genetically identical twin transplantation for chronic lymphocytic leukemia.

Author: Pavletic SZ; Zhou G; Sobocinski K; Marti G; Doney K; DiPersio J; Feremans W; Foroni L; Goodman S; Prentice G; LeMaistre C; Bandini G; Ferrant A; Jacobsen N; Khouri I; Gale RP; Wiestner A; Giralt S; Montserrat E; Chan WC; Bredeson C;
Institution: National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD 20892-1203, USA. pavletis@mail.nih.gov
Journal: Leukemia. 2007 Dec;21(12):2452-5. Epub 2007 Aug 30.
Abstract URL: Click here to view abstract

9. Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia.

Author: Weinberg JB; Volkheimer AD; Chen Y; Beasley BE; Jiang N; Lanasa MC; Friedman D; Vaccaro G; Rehder CW; Decastro CM; Rizzieri DA; Diehl LF; Gockerman JP; Moore JO; Goodman BK; Levesque MC;
Institution: Department of Medicine, Division of Hematology, VA and Duke University Medical Centers, 508 Fulton Street, Durham, North Carolina 27705, USA. brice@duke.edu
Journal: Am J Hematol. 2007 Dec;82(12):1063-70.
Abstract URL: Click here to view abstract

10. MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

Author: Gryshchenko I; Hofbauer S; Stoecher M; Daniel PT; Steurer M; Gaiger A; Eigenberger K; Greil R; Tinhofer I;
Institution: Laboratory for Immunological and Molecular Cancer Research, Third Medical Department, Salzburg University Hospital, Muellner Hauptstrasse 48, A-5020 Salzburg, Austria.
Journal: J Clin Oncol. 2008 May 10;26(14):2252-7.
Abstract URL: Click here to view abstract

11. Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century.

Author: Brenner H; Gondos A; Pulte D;
Institution: Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany. h.brenner@dkfz-heidelberg.de
Journal: Blood. 2008 May 15;111(10):4916-21. Epub 2008 Feb 28.
Abstract URL: Click here to view abstract

12. Chronic lymphocytic leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Author: Eichhorst B; Hallek M; Dreyling M;
Institution: Department of Internal Medicine I, University of Koln, Koln, Germany.
Journal: Ann Oncol. 2008 May;19 Suppl 2:ii60-2.

13. Evaluation of clinical staging in chronic lymphocytic leukemia- population-based study.

Author: Apelgren P; Hasselblom S; Werlenius O; Nilsson-Ehle H; Andersson PO;
Institution: Section of Haematology and Coagulation, Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden.
Journal: Leuk Lymphoma. 2006 Dec;47(12):2505-16.
Abstract URL: Click here to view abstract

14. Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience.

Author: Tsimberidou AM; O'Brien S; Kantarjian HM; Koller C; Hagemeister FB; Fayad L; Lerner S; Bueso-Ramos CE; Keating MJ;
Institution: Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. atsimber@mdanderson.org
Journal: Cancer. 2006 Sep 15;107(6):1294-302.
Abstract URL: Click here to view abstract

15. Emerging therapeutic options for B-cell disorders: idiopathic thrombocytopenic purpura and chronic lymphocytic leukemia.

Author: Goodrich A;
Institution: Johns Hopkins University, Kimmel Cancer Center, Baltimore, MD, USA. goodram@jhmi.edu
Journal: Clin J Oncol Nurs. 2007 Feb;11(1 Suppl):23-36.
Abstract URL: Click here to view abstract

16. Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia.

Author: Ripolles L; Ortega M; Ortuno F; Gonzalez A; Losada J; Ojanguren J; Soler JA; Bergua J; Coll MD; Caballin MR;
Institution: Anthropologic Biology Unit, Animal Biology, Vegetal Biology and Ecology Department, Autonomus University of Barcelona, Edifici C, 08193 Bellaterra, Barcelona, Spain.
Journal: Cancer Genet Cytogenet. 2006 Nov;171(1):57-64.
Abstract URL: Click here to view abstract

17. Recent Advances in the Treatment of CLL and NHL. A Review of Selected Presentations from the 43rd Annual Meeting of the American Society of Clinical Oncology, June 1-5, 2007, Chicago, Illinois.

Author
Institution
Journal: Clin Adv Hematol Oncol. 2007 Oct;5(10 Suppl 14):3-14, quiz 15-6.

18. Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia.

Author: Maddocks-Christianson K; Slager SL; Zent CS; Reinalda M; Call TG; Habermann TM; Bowen DA; Hoyer JD; Schwager S; Jelinek DF; Kay NE; Shanafelt TD;
Institution: Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Journal: Br J Haematol. 2007 Nov;139(3):398-404.
Abstract URL: Click here to view abstract

19. Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic test.

Author: Nowakowski GS; Hoyer JD; Shanafelt TD; Geyer SM; LaPlant BR; Call TG; Jelinek DF; Zent CS; Kay NE;
Institution: Division of Hematology, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. nowakowski.grzegorz@mayo.edu
Journal: Mayo Clin Proc. 2007 Apr;82(4):449-53.
Abstract URL: Click here to view abstract

20. Depression, anxiety and quality of life in a chronic lymphocytic leukemia cohort.

Author: Levin TT; Li Y; Riskind J; Rai K;
Institution: Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY 10022, USA.
Journal: Gen Hosp Psychiatry. 2007 May-Jun;29(3):251-6.
Abstract URL: Click here to view abstract

21. Skin lesions in chronic lymphocytic leukemia.

Author: Robak E; Robak T;
Institution: Department of Dermatology and Venereology, Medical University of Lodz. Poland.
Journal: Leuk Lymphoma. 2007 May;48(5):855-65.
Abstract URL: Click here to view abstract

22. Chronic lymphocytic leukemia: ESMO Clinical Recommendations for diagnosis, treatment and follow-up.

Author
Institution
Journal: Ann Oncol. 2007 May;18 Suppl 2:ii49-ii50.

23. Risk of second cancer after chronic lymphocytic leukemia.

Author: Schollkopf C; Rosendahl D; Rostgaard K; Pipper C; Hjalgrim H;
Institution: Department of Epidemiology Research, Statens Serum Institute, Copenhagen, Denmark.
Journal: Int J Cancer. 2007 Jul 1;121(1):2905-10.
Abstract URL: Click here to view abstract

24. Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.

Author: Brugiatelli M; Bandini G; Barosi G; Lauria F; Liso V; Marchetti M; Mauro FR; Meloni G; Zinzani PL; Tura S;
Institution: Divisione di Ematologia, Azienda Ospedaliera Papardo, Messina, Italy.
Journal: Haematologica. 2006 Dec;91(12):1662-73.
Abstract URL: Click here to view abstract

25. Abdominal computed tomography predicts progression in patients with Rai stage 0 chronic lymphocytic leukemia.

Author: Muntanola A; Bosch F; Arguis P; Arellano-Rodrigo E; Ayuso C; Gine E; Crespo M; Abrisqueta P; Moreno C; Cobo F; Lopez-Guillermo A; Montserrat E;
Institution: Department of Hematology, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain.
Journal: J Clin Oncol. 2007 Apr 20;25(12):1576-80. Epub 2007 Mar 12.
Abstract URL: Click here to view abstract

26. CLLU1 expression analysis adds prognostic information to risk prediction in chronic lymphocytic leukemia.

Author: Josefsson P; Geisler CH; Leffers H; Petersen JH; Andersen MK; Jurlander J; Buhl AM;
Institution: The Leukemia Laboratory, Dept of Hematology, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark.
Journal: Blood. 2007 Feb 6;.
Abstract URL: Click here to view abstract

27. T-cell ZAP-70 overexpression in chronic lymphocytic leukemia (CLL) correlates with CLL cell ZAP-70 levels, clinical stage and disease progression.

Author: Herishanu, Y; Kay, S; Rogowski, O; Pick, M; Naparstek, E; Deutsch, V R; Polliack, A;
Institution
Journal: Leukemia 2005 Jul;19(7):1289-91.

28. The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia.

Author: Glassman, Armand B; Hayes, Kimberly J;
Institution: Division of Pathology and Laboratory Medicine, Department of Hematopathology, Section of Cytogenetics, Unit 350, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA. aglassma@mdanderson.org
Journal: Cancer Genet Cytogenet 2005 Apr 1;158(1):88-91.
Abstract URL: Click here to view abstract